Search Results - "Berthou, Christelle"

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma by Facon, Thierry, Dimopoulos, Meletios-Athanasios, Leleu, Xavier P., Beksac, Meral, Pour, Ludek, Hájek, Roman, Liu, Zhuogang, Minarik, Jiri, Moreau, Philippe, Romejko-Jarosinska, Joanna, Spicka, Ivan, Vorobyev, Vladimir I., Besemer, Britta, Ishida, Tadao, Janowski, Wojciech, Kalayoglu-Besisik, Sevgi, Parmar, Gurdeep, Robak, Pawel, Zamagni, Elena, Goldschmidt, Hartmut, Martin, Thomas G., Manier, Salomon, Mohty, Mohamad, Oprea, Corina, Brégeault, Marie-France, Macé, Sandrine, Berthou, Christelle, Bregman, David, Klippel, Zandra, Orlowski, Robert Z.

“…More patients treated with isatuximab, bortezomib, lenalidomide, and dexamethasone had improved progression-free survival and had a complete or better response…”
Get full text

OA-49 Phase 3 Study Results of Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus VRd for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma (IMROZ) by Facon, Thierry, Dimopoulos, Meletios, Leleu, Xavier, Beksac, Meral, Pour, Ludek, Hájek, Roman, Liu, Zhuogang, Minarik, Jiri, Moreau, Philippe, Romejko-Jarosinska, Joanna, Spicka, Ivan, Vorobyev, Vladimir, Cavo, Michele, Goldschmidt, Hartmut, Martin, Thomas, Manier, Salomon, Brégeault, Marie-France, Macé, Sandrine, Berthou, Christelle, Orlowski, Robert

Get full text